OQROGet OQRO Pro
Politician trade (House)

Vertex Pharmaceuticals (VRTX)Rep. David J. Taylor (OH02) disclosed a sale $1K–$15K

Rep. David J. Taylor (OH02) disclosed a sale of Vertex Pharmaceuticals in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
10 days
Disclosure lag
Traded
Aug 26, 2026
Disclosed
Sep 5, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 27, 2026CongressDisclosed purchase of VRTX — reported range $1,001 - $15,000
  2. Jun 26, 2026InsiderOfficer sold ~$288K of VRTX shares in the open market
  3. Jul 1, 2026InsiderOfficer sold ~$416K of VRTX shares in the open market
  4. Jul 2, 2026Insider · 2 peopleInsiders: 2 sales (~$1.6M)
  5. Jul 6, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors (and 1 more item)
  6. Aug 3, 2026Company filing · Form 8-K · ResultsReported its results
  7. Aug 26, 2026 · this disclosureCongressDisclosed sale of VRTX — reported range $1,001 - $15,000

What came next

  1. Aug 27, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 27, 2026, Vertex Pharmaceuticals Incorporated (the “Company”) appointed Jonathan Poole as Executive Vice President and Chief Financial Officer of the Company, effective January 1, 2027 (the “Effective Date”).”
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Vertex Pharmaceuticals

For Vertex Pharmaceuticals, OQRO holds 2 Congress trade reports and 42 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VRTX page.

Other recent filings by Rep. David J. Taylor (OH02)

The full history of Rep. David J. Taylor (OH02) is on the profile page.

How this filing works

Other disclosures at Vertex Pharmaceuticals

Everything OQRO holds on this company is on its VRTX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data